Back to Menu
1. Clinical presentation assessment
A detailed history is obtained regarding typical manifestations such as right upper quadrant pain, gastrointestinal symptoms, and jaundice to provide an initial assessment.
2. Ultrasonography
The first-line modality for surveillance and screening, used to detect intrahepatic lesions; color Doppler evaluates vascular characteristics.
3. CT and MRI
Contrast-enhanced studies delineate tumor size, location, and vascularity; MRI is more sensitive for small nodules.
4. Alpha-fetoprotein testing
An important serum marker; markedly elevated AFP has significant diagnostic value for hepatocellular carcinoma.
5. Pathological biopsy
Imaging-guided needle biopsy provides tissue for histopathology and is the gold standard for confirming tumor type and guiding treatment.
6. Liver function testing
Assessment of aminotransferases, bilirubin, albumin, and related indices to determine hepatic reserve.
7. Other tumor markers
Markers such as AFP-L3 can increase diagnostic yield in cases without AFP elevation.
8. Systemic evaluation
Chest CT, bone scanning, and other examinations are performed to evaluate distant metastasis and determine clinical stage to guide treatment.
9. Daily self-check for liver cancer
Pay attention to symptoms such as right upper quadrant discomfort and fatigue; however, early detection depends on regular ultrasonography and AFP testing in high-risk populations.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that liver cancer is life-threatening, and late-stage diagnosis adversely affects treatment outcomes. Early detection through imaging and laboratory testing is pivotal. Stage- and liver function–adapted individualized strategies integrating surgery, interventional procedures, ablation, and targeted therapies are required to improve cure rates and quality of survival.
1. Clinical presentation assessment
A detailed history is obtained regarding typical manifestations such as right upper quadrant pain, gastrointestinal symptoms, and jaundice to provide an initial assessment.
2. Ultrasonography
The first-line modality for surveillance and screening, used to detect intrahepatic lesions; color Doppler evaluates vascular characteristics.
3. CT and MRI
Contrast-enhanced studies delineate tumor size, location, and vascularity; MRI is more sensitive for small nodules.
4. Alpha-fetoprotein testing
An important serum marker; markedly elevated AFP has significant diagnostic value for hepatocellular carcinoma.
5. Pathological biopsy
Imaging-guided needle biopsy provides tissue for histopathology and is the gold standard for confirming tumor type and guiding treatment.
6. Liver function testing
Assessment of aminotransferases, bilirubin, albumin, and related indices to determine hepatic reserve.
7. Other tumor markers
Markers such as AFP-L3 can increase diagnostic yield in cases without AFP elevation.
8. Systemic evaluation
Chest CT, bone scanning, and other examinations are performed to evaluate distant metastasis and determine clinical stage to guide treatment.
9. Daily self-check for liver cancer
Pay attention to symptoms such as right upper quadrant discomfort and fatigue; however, early detection depends on regular ultrasonography and AFP testing in high-risk populations.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that liver cancer is life-threatening, and late-stage diagnosis adversely affects treatment outcomes. Early detection through imaging and laboratory testing is pivotal. Stage- and liver function–adapted individualized strategies integrating surgery, interventional procedures, ablation, and targeted therapies are required to improve cure rates and quality of survival.